The University of Puerto Rico, Río Piedras Campus is a public land-grant research university in San Juan, Puerto Rico. It is the largest campus in the University of Puerto Rico system in terms of student population and it was Puerto Rico's first public university campus.

During the past decade, University of Puerto Rico conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 18 clinical trials were completed, i.e. on average, 58.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Puerto Rico" #1 sponsor was "National Cancer Institute (NCI)" with 12 trials, followed by "University of North Carolina, Chapel Hill" with 8 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials sponsored, "AIDS Malignancy Consortium" with 3 trials sponsored and "Eli Lilly and Company" with 3 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Puerto Rico" #1 collaborator was "National Institute on Drug Abuse (NIDA)" with 9 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 8 trials as a collaborator, "University of Puerto Rico" with 7 trials as a collaborator, "National Cancer Institute (NCI)" with 6 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "University of Puerto Rico" are "HIV Infections" (12 trials), "Healthy" (4 trials), "Depression" (3 trials), "Familial Adenomatous Polyposis" (3 trials) and "HIV Infection" (3 trials). Many other conditions were trialed in "University of Puerto Rico" in a lesser frequency.

Most popular intervention types in "University of Puerto Rico" are "Drug" (32 trials), "Other" (22 trials), "Biological" (10 trials), "Procedure" (8 trials) and "Behavioral" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Laboratory Biomarker Analysis" (6 trials), "Questionnaire Administration" (6 trials), "Biospecimen Collection" (5 trials) and "Placebo Administration" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Puerto Rico" are 61 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Puerto Rico". 1 are not yet recruiting, 8 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in University of Puerto Rico, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Puerto Rico, 6 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".

University of Puerto Rico has several departments that took part in Clinical trials: "Univ of Puerto Rico / Univ Children's Hosp AIDS" - 26 trials, "Puerto Rico Cancer Center at University of Puerto Rico - Medical Sciences Campus" - 11 trials, "University Pediatric Hospital" - 71 trials, "Trauma Unit University of Puerto Rico Medical Center" - 2 trials, "University of Puerto Rico, School of Medicine, Proyecto ACTU" - 2 trials, "University of Puerto Rico - Medical Science Campus; Internal Medicine" - 2 trials